Debaosheng

Ashwagandha Black Maca Extract Powde

Shenzhen Deyintang Biotechnology Co., Ltd.
Human Otc Drug
NDC 82570-012

Debaosheng also known as Ashwagandha Black Maca Extract Powde is a human otc drug labeled by 'Shenzhen Deyintang Biotechnology Co., Ltd.'. National Drug Code (NDC) number for Debaosheng is 82570-012. This drug is available in dosage form of Capsule. The names of the active, medicinal ingredients in Debaosheng drug includes Lepidium Meyenii Whole - 10 g/100g Turnera Diffusa Leaf - 10 g/100g Withania Somnifera Root - 52 g/100g . The currest status of Debaosheng drug is Active.

Drug Information:

Drug NDC:	82570-012
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Debaosheng
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Ashwagandha Black Maca Extract Powde
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Shenzhen Deyintang Biotechnology Co., Ltd.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Capsule
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	LEPIDIUM MEYENII WHOLE - 10 g/100g TURNERA DIFFUSA LEAF - 10 g/100g WITHANIA SOMNIFERA ROOT - 52 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	22 Feb, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Shenzhen Deyintang Biotechnology Co., Ltd.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	94866V8426 812R0W1I3K V038D626IF
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
82570-012-01	.5 g in 1 BOTTLE (82570-012-01)	22 Feb, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Debaosheng

Ashwagandha Black Maca Extract Powde

Capsule
Shenzhen Deyintang Biotechnology Co., Ltd.
NDC: 82570-012

Purpose:

Health care

Product Elements:

Debaosheng ashwagandha black maca extract powde lepidium meyenii whole lepidium meyenii whole carrageenan withania somnifera root withania somnifera root turnera diffusa leaf turnera diffusa leaf potassium chloride hypromelloses debaosheng

Indications and Usage:

Please eat according to the recommended amount,it is not beneficial to eat too much.

Warnings:

1.please avoid children taking it by themselves. 2.please eat according to the recommended amount,it is not beneficial to eat too much. 3.please keep in a cool and dry place and avoid directsunlight and high temperature.

Dosage and Administration:

Consumption method and dosage 1-2 times a day, 1-2 capsules each time,eat with warm water before meals.

Package Label Principal Display Panel:

Label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.